Clinical trialNCT02186665CompletedPhase 4Interventional

Plaque Psoriasis Study in Pediatric Subjects

SponsorGalderma R&DEnrollment19Plaque Psoriasis

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to compare the safety, efficacy and calcium metabolism of up to 8 weeks of treatment with calcitriol 3 mcg/g ointment versus its vehicle, when used twice daily, without occlusion, to treat children aged 2 to 12 years, with plaque psoriasis.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Michael Graeber, MD
Galderma R&D, LLC
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

34 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Belgium

Ucl Saint Luc
Brussels, Belgium
Uz Ghent
Ghent, Belgium
Chu de Liège
Liège, Belgium

Canada

Winnipeg Clinic, Dermatology Research
Winnipeg, Manitoba, Canada

Germany

Universitätsklinikum Erlangen, Hautklinik
Erlangen, Germany
Praxis Dr.Beate Schwarz
Langenau, Germany
Universitäts-Hautklinik Mainz, Johannes Gutenberg-Universität Mainz
Mainz, Germany
Technical University Munich
München, Germany
University of Tübingen
Tübingen, Germany

Hungary

Heim Pál Gyermekkórház; Bőrgyógyászati Osztály
Budapest, Hungary
Pécsi Tudományegyetem; Bőr-, Nemikórtani És Onkodermatológiai Klinika
Pécs, Hungary
Szegedi Tudományegyetem, Szent-Györgyi Albert Klinikai Központ; Bőrgyógyászati És Allergológiai Klinika
Szeged, Hungary

Italy

Po G. Rodolico, Aou Policlinico Vittorio Emanuele
Catania, Italy
Padova University Hospital
Padova, Italy
University of Parma
Parma, Italy
Policlinico Tor Vergata
Rome, Italy

Spain

Hospital Universitari Germans Trias I Pujol
Badalona-Barcelona, Spain
Hospital Sant Joan de Deu
Esplugues de Llobregat, Spain
Hospital General Universitario Gregorio Marañón
Madrid, Spain
Hospital Universitario Infanta Leonor
Madrid, Spain
Hospital Universitario la Paz
Madrid, Spain
Hospital Universitario Infanta Sofía
San Sebastián de los Reyes, Spain

United States

David Stoll, Md
Beverly Hills, California, United States
Center for Dermatology and Laser Surgery
Sacramento, California, United States
Dermatology Specialists Research
Louisville, Kentucky, United States
University of Mississippi Medical Center
Jackson, Mississippi, United States
Rcmc Center for Dermatology at Linden Oaks
Rochester, New York, United States
Montefiore Medical Center
The Bronx, New York, United States
Clinical Partners, Llc
Johnston, Rhode Island, United States
Dermatology and Laser Center of Charleston
Charleston, South Carolina, United States
Dermresearch
Austin, Texas, United States
the University of Texas Health Science Center at Houston
Houston, Texas, United States
Clinical Trials of Texas
San Antonio, Texas, United States
Jordan Valley Dermatology
West Jordan, Utah, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Calcitriol →Placebo comparator

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Jul 2014
Primary completion: 30 Nov 2015
Completion: 31 Jan 2016
Last update posted: 18 Feb 2021
Registered enrollment: 19
Registry id: NCT02186665

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.